$PRLB

Schumacher Daniel sold $426K of PRLB

Schumacher Daniel (Chief Financial Officer) sold 5,000 shares of Proto Labs Inc (PRLB) at an average of $85.21 ($85.00–$85.21, $0.43M total) across 2 trades over 2026-09-16 to 2026-09-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Schumacher Daniel
Published Sep 18, 2026, 8:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 8:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PRLB
Neutral
medium confidence
Mentioned
$PRLB
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PRLBNeutralLow
01

Why it matters

The CFO's sale reduces insider ownership but is pre‑arranged, so market reaction may be muted.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

No change in company fundamentals; the CFO may be diversifying personal holdings.

Relevance 3/10Novelty 4/10Timing: filed Sep 18, 2026

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$PRLBNeutralMedium confidence
Context

CFO Daniel Schumacher sold 5,000 shares for $426K via a 10b5-1 plan, reducing his stake to 40,019 shares.

Expected impact

Possible modest downward pressure in the next trading session.

Evidence & confidence

The sale size is modest relative to market cap and follows a pre‑arranged plan, limiting informational value.

Market effects

Minimal impact on the broader manufacturing services sector.

Limited to US investors tracking Proto Labs.

Low

Counterpoint

The sale could be a routine liquidity event, not a negative signal.

Key entities

  • Proto Labs Inc

    US‑listed manufacturer of rapid prototyping services (ticker PRLB).

  • Daniel Schumacher

    Chief Financial Officer of Proto Labs.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ARWMed

Arrow Electronics, Methode Electronics, Proto Labs, and SolarEdge Shares Skyrocket, What You Need To Know

Arrow Electronics (ARW), Methode Electronics (MEI), Proto Labs (PRLB), and SolarEdge (SEDG) shares rose after weaker-than-expected U.S. jobs data lowered Treasury yields. The Bureau of Labor Statistics reported nonfarm payrolls increased by 29,000 in September, below expectations. Lower yields ease borrowing costs for industrial companies, but slower hiring may signal economic cooling. SolarEdge's stock is up 5.4% year-to-date but remains 57.9% below its 52-week high.

$PRLBMed

Is Proto Labs (PRLB) Fully Valued As A New COO Reshapes Operations?

Proto Labs (PRLB) appointed Sam Ramahi as Chief Operations Officer, focusing on operational leadership and global supply chain management. The stock has seen a 12-month total shareholder return of 60.09% and a year-to-date return of 55.29%, closing at $79.74. Analysts debate whether the current price reflects its shift, with a fair value estimate of $95.50, citing strong cash generation and growth potential. However, risks include customer concentration and weakness in Europe, and the stock trad

$PRLBLow

Protolabs Names Sam Ramahi COO to Lead Global Manufacturing Operations

Protolabs (PRLB) appointed Sam Ramahi as COO to lead global operations. Ramahi, with 25 years of experience, will oversee supply chain, quality, and continuous improvement. He previously led operations at SIG Group and Jacuzzi. The move supports Protolabs' strategy to expand from prototyping to production, aiming to improve performance and create value for shareholders.

$PRLBHighAI 9/10

Proto Labs (PRLB) Q2 2026 Earnings Call Transcript

Proto Labs (NYSE:PRLB) reported Q2 FY2026 revenue of $149.3 million, up 10.2% in constant currency, and non-GAAP EPS of $0.60. Non-GAAP gross margin rose to 46.8%. Q3 revenue guidance is $145 million to $153 million, with non-GAAP EPS of $0.56 to $0.64. Full-year 2026 revenue growth guidance was raised to 8% to 10%.

$PRLBHighAI 9/10

Proto Labs (PRLB) Q2 2026 Earnings Call Transcript

Proto Labs (PRLB) reported Q2 FY2026 revenue of $149.3 million, up 10.2% in constant currency, with non-GAAP EPS of $0.60. Non-GAAP gross margin rose to 46.8% and adjusted EBITDA was $25.1 million. Q3 revenue guidance is $145 million to $153 million, and full-year 2026 revenue growth guidance was raised to 8% to 10%. Cash and investments were $162.9 million with zero debt.